✦ LIBER ✦

Pegylated Interferons for the Treatment of Chronic Hepatitis C

✍ Scribed by Foster, Graham R.

Book ID: 118157690
Publisher: Springer International Publishing AG
Year: 2010
Tongue: English
Weight: 218 KB
Volume: 70
Category: Article
ISSN: 0012-6667
DOI: 10.2165/11531990-000000000-00000

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pegylated interferons in combination wit

Pegylated interferons in combination with ribavirin for the treatment of chronic hepatitis C

✍ Markus Cornberg; Heiner Wedemeyer; Michael P. Manns 📂 Article 📅 2003 🏛 Current Science Inc. 🌐 English ⚖ 313 KB

ARE ELDERLY PATIENTS POOR CANDIDATES FOR

ARE ELDERLY PATIENTS POOR CANDIDATES FOR PEGYLATED INTERFERON PLUS RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C?

✍ Annarosa Floreani; Eliseo Minola; Isabella Carderi; Francesco Ferrara; Erik Rosa 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Pegylated interferon α-2b plus ribavirin

Pegylated interferon α-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-coinfected patients

✍ Esther Voigt; Christian Schulz; Gerd Klausen; Joerg Goelz; Stefan Mauss; Guenthe 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Detection of hepatocellular carcinoma du

Detection of hepatocellular carcinoma during the treatment with pegylated interferon alfa-2a and ribavirin for chronic hepatitis C

✍ M. Capanni; E. Lorefice; M.C. Benini; M.R. Biagini; A. Tozzi; A. Galli; C. Surre 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Pegylated interferon alfa-2B (PEG-intron

Pegylated interferon alfa-2B (PEG-intron) mono-therapy is superior to interferon alfa-2B (intron A) for the treatment of chronic hepatitis C

✍ C. Trepo; K. Lindsay; C. Niederau; M. Shiffman; S. Gordon; J. Hoefs; E. Schiff; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Variants in interferon-alpha pathway gen

Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial

✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may